Schedule 13G ownership disclosure

WEST PHARMACEUTICAL SVSC INC COM

Common Stock · CUSIP: 955306105

Event date: 2025-09-30

Filing-level shares
9,704,948
Percent of class
13.49%
  • The Vanguard Group

    Shares: 9,704,948 · Class: 13.49%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000329
Form type
SCHEDULE 13G/A
Filer
VANGUARD GROUP INC
CIK
CIK 102909
Filed
Oct 31, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub